Treatment Indications: correction of moderate to deep wrinkles and folds (nasolabial folds, marionette lines, glabellar lines, forehead creases);, mid‑face volumization (cheeks, temples);, chin and jawline contouring;, non‑surgical rhinoplasty and nasal ridge refinement;, restoration of moderate to severe volume deficits and facial structural support;, achieving defined facial contours with stable projection
Release form: 1 × 1.0 mL pre‑filled sterile glass syringe
Indications: mid to deep dermal and subdermal injection for correction of deep wrinkles, folds, and volume deficits;, monophasic gel utilizing proprietary HI (High Integration) cross‑linking technology for high viscosity, superior elasticity, and stable shape retention;, providing balanced viscoelasticity, minimal migration, and natural-looking contouring with residual BDDE below 0.1 ppm (effect duration ~9–12 months)